RNA interference suppression of Nogo-66 receptor prevents Nogo-66-mediated inhibition of invasion and adhesion and simultaneously increases cell apoptosis in C6 cells

Tong,Song; Xiong,Nanxiang; Shen,Jianying

doi:10.3892/or.2013.2694

RNA interference suppression of Nogo-66 receptor prevents Nogo-66-mediated inhibition of invasion and adhesion and simultaneously increases cell apoptosis in C6 cells

Authors:
- Song Tong
- Nanxiang Xiong
- Jianying Shen
View Affiliations

Affiliations: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, P.R. China, Section of Histology and Embryology, Department of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, P.R. China
Published online on: August 26, 2013 https://doi.org/10.3892/or.2013.2694
Pages: 2171-2178

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gliomas are the most common primary tumors of the central nervous system (CNS). Nogo-66 is an extracellular domain of Nogo-A, which can block axon regeneration in the CNS after trauma. Some studies have indicated that Nogo-A and its receptor (NgR) are expressed in tumor tissues; however, their roles in tumors are still unknown. We report the impact of Nogo-66 and NgR on the proliferation, apoptosis, adhesion and invasion of C6 glioma cells. Short hairpin RNA (shRNA)-triggered RNA interference was used to inhibit NgR expression in C6 cells. Then, an in vitro cell adhesion assay was performed to assess the effect of NgR downregulation on the adhesion ability of C6 cells. In addition, a chamber assay and a cell scratch assay were conducted to test invasion ability. The spontaneous apoptosis of C6 cells was examined by flow cytometry, western blotting and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. NgR downregulation resulted in a significant increase of C6 adhesion and invasion activity in the presence of Nogo-66, markedly inhibited proliferation and induced spontaneous apoptosis. In conclusion, knockdown of NgR enhanced invasion and adhesion but increased cell apoptosis in C6 cells, suggesting that Nogo-66/NgR might have complex effects on glioma cells.

View Figures

View References

1	Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F and Schwab ME: Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:434–439. 2000. View Article : Google Scholar : PubMed/NCBI
2	Fournier AE, GrandPre T and Strittmatter SM: Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:341–346. 2001. View Article : Google Scholar : PubMed/NCBI
3	Liao H, Duka T, Teng FY, Sun L, Bu WY, Ahmed S, Tang BL and Xiao ZC: Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J Neurochem. 90:1156–1162. 2004. View Article : Google Scholar : PubMed/NCBI
4	Xiong N, Shen J, Li S, Li J and Zhao H: Expression of Nogo-66 receptor in human astrocytoma is correlated with tumor malignancy. Mol Biol Rep. 39:2625–2632. 2012. View Article : Google Scholar : PubMed/NCBI
5	Kilic E, ElAli A, Kilic U, Guo Z, Ugur M, Uslu U, Bassetti CL, Schwab ME and Hermann DM: Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab. 30:969–984. 2010. View Article : Google Scholar : PubMed/NCBI
6	Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239–3245. 1987.PubMed/NCBI
7	Kawajiri H, Yashiro M, Shinto O, Nakamura K, Tendo M, Takemura S, Node M, Hamashima Y, Kajimoto T, Sawada T, et al: A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res. 14:2850–2860. 2008. View Article : Google Scholar : PubMed/NCBI
8	Nishimura S, Chung YS, Yashiro M, Inoue T and Sowa M: Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer. 74:1406–1412. 1996. View Article : Google Scholar : PubMed/NCBI
9	Dasari VR, Velpula KK, Kaur K, Fassett D, Klopfenstein JD, Dinh DH, Gujrati M and Rao JS: Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS One. 5:e118132010. View Article : Google Scholar : PubMed/NCBI
10	Friedlander DR, Zagzag D, Shiff B, Cohen H, Allen JC, Kelly PJ and Grumet M: Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Res. 56:1939–1947. 1996.PubMed/NCBI
11	Yang HW, Menon LG, Black PM, Carroll RS and Johnson MD: SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer. 10:3012010. View Article : Google Scholar : PubMed/NCBI
12	Eroglu C: The role of astrocyte-secreted matricellular proteins in central nervous system development and function. J Cell Commun Signal. 3:167–176. 2009. View Article : Google Scholar : PubMed/NCBI
13	Irintchev A, Rollenhagen A, Troncoso E, Kiss JZ and Schachner M: Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cereb Cortex. 15:950–962. 2005. View Article : Google Scholar : PubMed/NCBI
14	Giese A, Loo MA, Rief MD, Tran N and Berens ME: Substrates for astrocytoma invasion. Neurosurgery. 37:294–302. 1995. View Article : Google Scholar : PubMed/NCBI
15	Giese A, Rief MD, Loo MA and Berens ME: Determinants of human astrocytoma migration. Cancer Res. 54:3897–3904. 1994.PubMed/NCBI
16	Amberger VR, Hensel T, Ogata N and Schwab ME: Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 58:149–158. 1998.PubMed/NCBI
17	Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, Akiba S, Miyadera K, Fukushima M, Yamada Y, et al: The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res. 59:1911–1916. 1999.PubMed/NCBI
18	Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
19	Rossi L, De Martino A, Marchese E, Piccirilli S, Rotilio G and Ciriolo MR: Neurodegeneration in the animal model of Menkes’ disease involves Bcl-2-linked apoptosis. Neuroscience. 103:181–188. 2001.
20	Hengartner MO: The biochemistry of apoptosis. Nature. 407:770–776. 2000. View Article : Google Scholar : PubMed/NCBI
21	Yan J, Zhou X, Guo JJ, Mao L, Wang YJ, Sun J, Sun LX, Zhang LY, Zhou XF and Liao H: Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro. J Neurochem. 120:721–731. 2012. View Article : Google Scholar